Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasis.
D000328:Adult; D000368:Aged; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D017313:Fenretinide; D006801:Humans; D008297:Male; D009755:Night Blindness / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy; D014212:Tretinoin / Q000009:adverse effects / Q000031:analogs & derivatives*
D017313:Fenretinide; D014212:Tretinoin